112 related articles for article (PubMed ID: 9987145)
1. A routine high-performance size-exclusion chromatography to determine molecular size distribution of Haemophilus influenzae type b conjugate vaccines.
von Hunolstein C; Parisi L; Recchia S
Vaccine; 1999 Jan; 17(2):118-25. PubMed ID: 9987145
[TBL] [Abstract][Full Text] [Related]
2. Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants.
Klein NP; Abu-Elyazeed R; Cornish M; Leonardi ML; Weiner LB; Silas PE; Grogg SE; Varman M; Frenck RW; Cheuvart B; Baine Y; Miller JM; Leyssen M; Mesaros N; Roy-Ghanta S
Vaccine; 2017 Jun; 35(28):3564-3574. PubMed ID: 28536030
[TBL] [Abstract][Full Text] [Related]
3. Development and characterization of Haemophilus influenzae type b conjugate vaccine prepared using different polysaccharide chain lengths.
Rana R; Dalal J; Singh D; Kumar N; Hanif S; Joshi N; Chhikara MK
Vaccine; 2015 May; 33(23):2646-54. PubMed ID: 25907408
[TBL] [Abstract][Full Text] [Related]
4. Endotoxin content in Haemophilus influenzae type b vaccine.
Ochiai M; Kataoka M; Toyoizumi H; Yamamoto A; Kamachi K; Arakawa Y; Kurata T; Horiuchi Y
Jpn J Infect Dis; 2004 Apr; 57(2):58-9. PubMed ID: 15118211
[TBL] [Abstract][Full Text] [Related]
5. Use of immuno assays during the development of a Hemophilus influenzae type b vaccine for technology transfer to emerging vaccine manufacturers.
Hamidi A; Kreeftenberg H
Hum Vaccin Immunother; 2014; 10(9):2697-703. PubMed ID: 25483494
[TBL] [Abstract][Full Text] [Related]
6. Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled trial.
Iro MA; Khatami A; Marshall AS; Pace D; Voysey M; McKenna J; Campbell D; Attard-Montalto S; Finn A; White C; Faust SN; Kent A; Heath PT; MacLeod E; Stanford E; Findlow H; Almond R; Bai X; Borrow R; Snape MD; Pollard AJ
Lancet Infect Dis; 2015 Feb; 15(2):172-80. PubMed ID: 25577661
[TBL] [Abstract][Full Text] [Related]
7. Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens.
Lagos R; Valenzuela MT; Levine OS; Losonsky GA; Erazo A; Wasserman SS; Levine MM
Lancet; 1998 May; 351(9114):1472-6. PubMed ID: 9605803
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.
Hu JL; Tao H; Li JX; Dai WM; Song B; Sun JF; Liu P; Tang J; Liu WY; Wang SY; Zhu FC
Hum Vaccin Immunother; 2015; 11(5):1120-8. PubMed ID: 25833163
[TBL] [Abstract][Full Text] [Related]
9. Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the immune response to antigens contained in infant vaccines routinely used in the United States.
Marshall GS; Marchant CD; Blatter M; Friedland LR; Aris E; Miller JM
Hum Vaccin; 2011 Feb; 7(2):258-64. PubMed ID: 21307655
[TBL] [Abstract][Full Text] [Related]
10. Suppression and modulation of cellular and humoral immune responses to Haemophilus influenzae type B (Hib) conjugate vaccine in hib-diphtheria-tetanus toxoids-acellular pertussis combination vaccines: a study in a rat model.
Mawas F; Newman G; Burns S; Corbel MJ
J Infect Dis; 2005 Jan; 191(1):58-64. PubMed ID: 15593004
[TBL] [Abstract][Full Text] [Related]
11. Antibody responses of three Haemophilus influenzae type b conjugate vaccines after one, two and three doses in Filipino children.
Capeding MR; Nohynek H; Käyhty H; Pascual LG; Sunico ES; Tamundong AA; Ruutu P
Vaccine; 1998; 16(9-10):1004-8. PubMed ID: 9682351
[TBL] [Abstract][Full Text] [Related]
12. A combined Haemophilus influenzae type B Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when coadministered with diphtheria, tetanus, acellular pertussis hepatitis B-inactivated poliovirus at 3, 5 and 11 months of age: results of an open, randomized, controlled study.
Vesikari T; Forstén A; Desole MG; Ferrera G; Caubet M; Mesaros N; Boutriau D
Pediatr Infect Dis J; 2013 May; 32(5):521-9. PubMed ID: 23190785
[TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of a Haemophilus influenzae type b conjugate vaccine process intended for technology transfer.
Hamidi A; Verdijk P; Kreeftenberg H
Hum Vaccin Immunother; 2014; 10(9):2691-6. PubMed ID: 25483504
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants.
Lee CY; Thipphawong J; Huang LM; Lee PI; Chiu HH; Lin W; Debois H; Harrison D; Xie F; Barreto L
Pediatrics; 1999 Jan; 103(1):25-30. PubMed ID: 9917435
[TBL] [Abstract][Full Text] [Related]
15. Combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C (HibMenC) or serogroup C and Y-tetanus toxoid conjugate (and HibMenCY) vaccines are well-tolerated and immunogenic when administered according to the 2,3,4 months schedule with a fourth dose at 12-18 months of age.
Habermehl P; Leroux-Roels G; Sänger R; Mächler G; Boutriau D
Hum Vaccin; 2010 Aug; 6(8):640-51. PubMed ID: 20697200
[TBL] [Abstract][Full Text] [Related]
16. Determination of the molecular size distribution of Haemophilus influenzae type b-tetanus toxoid conjugate vaccines by size-exclusion chromatography.
Parisi L; von Hunolstein C
J Chromatogr A; 1999 Jun; 847(1-2):209-11. PubMed ID: 10431361
[TBL] [Abstract][Full Text] [Related]
17. Stability testing in Haemophilus influenzae type b conjugate vaccines.
Klug B
Dev Biol Stand; 1996; 87():263-7. PubMed ID: 8854026
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
[TBL] [Abstract][Full Text] [Related]
19. A fully liquid diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis--Haemophilus influenzae type b conjugate vaccine: immunogenicity and safety of primary vaccination in Taiwanese infants.
Lin TY; Wang YH; Chang LY; Huang YC; Kao HT; Lin PY; Lu HK; Chavand P; Ortiz E
Int J Infect Dis; 2007 Mar; 11(2):129-36. PubMed ID: 16762579
[TBL] [Abstract][Full Text] [Related]
20. Administration of combined diphtheria and tetanus toxoids and pertussis vaccine, hepatitis B vaccine, and Haemophilus influenzae type b (Hib) vaccine to infants and response to a booster dose of Hib conjugate vaccine.
Pichichero ME; Passador S
Clin Infect Dis; 1997 Dec; 25(6):1378-84. PubMed ID: 9431382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
